The technology, developed in part by the U.S. Department of Defense (DoD), examines vital signs and other biomarkers to predict the likelihood of infection up to 48 hours ahead of clinical suspicion, according to an article on the Healthcare IT News website.
The technology is intended for U.S. service members but expected to be used widely by civilians.
The healthcare technology company, Royal Philips, and the DoD collaborated on the 18-month project.
The technology is expected to be broadly applicable to civilian healthcare settings. It will eventually be used in scenarios where vital signs and biomarkers fluctuate, like during physical exertion and heat stress.
Healthcare Real Estate: Responding to Shifting Patient Demands
Over 40% of Workers Impacted by Seasonal Depression
Archer Property Partners Acquires Medical Office Building Near Tri-City Hospital
The OR HVAC Puzzle: Why Individual Systems Are on the Rise
Sutter Health Announces Plans for New Santa Clara Medical Center